Patent · US Active

Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies

US10118967B2 · kind B2 · utility

8Cited by

12References

13Claims

0Family size

Assignee

Ablynx N.V. · BE

Inventors

Sven Hoefman · Kortrijk, BE
Maria-Laura Sargentini-Maier · Brussels, BE
Katrien Van Beneden · Scheldewindeke, BE

Key dates

Filing date	Oct 21, 2015
Grant date	Nov 6, 2018
Priority date	—
Expiry date	Oct 21, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.